AU1745283A - Herpes antigen from engineered e.coli - Google Patents

Herpes antigen from engineered e.coli

Info

Publication number
AU1745283A
AU1745283A AU17452/83A AU1745283A AU1745283A AU 1745283 A AU1745283 A AU 1745283A AU 17452/83 A AU17452/83 A AU 17452/83A AU 1745283 A AU1745283 A AU 1745283A AU 1745283 A AU1745283 A AU 1745283A
Authority
AU
Australia
Prior art keywords
engineered
coli
hsv
vectors
herpes antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU17452/83A
Other versions
AU577516B2 (en
Inventor
Michael Broker
Ernst-Ludwig Winnacker
Hans Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU1745283A publication Critical patent/AU1745283A/en
Application granted granted Critical
Publication of AU577516B2 publication Critical patent/AU577516B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

1. A process for the preparation of glycoprotein C of herpes simplex virus type 1 (HSV-1) or immunogenic components thereof, which comprises introducing the HindIII L fragment of HSV-1 or part fragments which encode these immunogenic components into vectors, and transforming pro- or eukaryotic cells with these vectors and causing them to be expressed in the transformants.
AU17452/83A 1982-07-30 1983-07-29 Herpes antigen from engineered e.coli Ceased AU577516B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3228501 1982-07-30
DE19823228501 DE3228501A1 (en) 1982-07-30 1982-07-30 METHOD FOR PRODUCING A HERPES ANTIGENT, MEANS THAT ARE SUITABLE FOR ITS PRODUCTION, AND METHOD FOR THE PRODUCTION THEREOF AND THE USE OF THIS ANTIQUE

Publications (2)

Publication Number Publication Date
AU1745283A true AU1745283A (en) 1984-02-02
AU577516B2 AU577516B2 (en) 1988-09-29

Family

ID=6169723

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17452/83A Ceased AU577516B2 (en) 1982-07-30 1983-07-29 Herpes antigen from engineered e.coli

Country Status (7)

Country Link
EP (1) EP0100521B1 (en)
JP (1) JPS5948095A (en)
AT (1) ATE56044T1 (en)
AU (1) AU577516B2 (en)
CA (1) CA1273884A (en)
DE (2) DE3228501A1 (en)
IL (1) IL69374A0 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818694A (en) * 1982-07-20 1989-04-04 American Cyanamid Company Production of herpes simplex viral protein
AU583478B2 (en) * 1983-08-30 1989-05-04 Genentech Inc. Molecularly cloned diagnostic product and method of use
US5851533A (en) * 1983-08-30 1998-12-22 Genentech, Inc. Vaccine based on membrane bound proteins and process for making them
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT77014B (en) * 1982-07-20 1986-01-24 Molecular Genetics Inc Production of herpes simplex viral proteins
JPS6051120A (en) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst Herpes simplex subunit vaccine
US4642333A (en) * 1983-09-16 1987-02-10 Stanley Person Immunologically reactive non-glycosylated amino acid chains of glycoprotein B of herpes virus types 1 and 2
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
ATE230798T1 (en) * 1984-04-06 2003-01-15 Chiron Corp RECOMBINANT HERPES SIMPLEX GB-GD VACCINE
JPS615786A (en) * 1984-06-19 1986-01-11 Chemo Sero Therapeut Res Inst Recombinant dna having integrated herpes simplex virus, transformant animal cell and production of herpes simplex virus protein
EP0170169B1 (en) * 1984-07-20 1991-03-20 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant dna containing a herpes simplex virus gene or a fragment thereof, yeast transformed with said recombinant dna, and method for the production of herpes simplex virus proteins
JPS6153226A (en) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst Purification of simple herpes subunit vaccine
US4659568A (en) * 1985-02-27 1987-04-21 American Cyanamid Company Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
DE3510734A1 (en) * 1985-03-25 1986-09-25 Behringwerke Ag, 3550 Marburg METHOD FOR PRODUCING A HERPES SIMPLEX VIRUS TYPE 2-SPECIFIC ANTIQUE, MEANS THAT ARE SUITABLE FOR THIS, AND USE OF THIS ANTIQUE
JPH0668B2 (en) * 1985-08-30 1994-01-05 財団法人化学及血清療法研究所 Recombinant plasmid with herpes simplex virus gene

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (en) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostic antibody and procedure for its preparation
PT77014B (en) * 1982-07-20 1986-01-24 Molecular Genetics Inc Production of herpes simplex viral proteins
AU1678783A (en) * 1982-07-20 1984-01-26 Molecular Genetics, Inc. Production of herpes simplex viral proteins
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818694A (en) * 1982-07-20 1989-04-04 American Cyanamid Company Production of herpes simplex viral protein
AU583478B2 (en) * 1983-08-30 1989-05-04 Genentech Inc. Molecularly cloned diagnostic product and method of use
AU623375B2 (en) * 1983-08-30 1992-05-14 Genentech Inc. Molecularly cloned diagnostic product and method of use
US5851533A (en) * 1983-08-30 1998-12-22 Genentech, Inc. Vaccine based on membrane bound proteins and process for making them
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it

Also Published As

Publication number Publication date
AU577516B2 (en) 1988-09-29
DE3381843D1 (en) 1990-10-04
EP0100521A3 (en) 1985-12-04
DE3228501A1 (en) 1984-02-02
EP0100521A2 (en) 1984-02-15
IL69374A0 (en) 1983-11-30
ATE56044T1 (en) 1990-09-15
EP0100521B1 (en) 1990-08-29
CA1273884A (en) 1990-09-11
JPS5948095A (en) 1984-03-19

Similar Documents

Publication Publication Date Title
AU577516B2 (en) Herpes antigen from engineered e.coli
ES8705036A1 (en) Vaccines based on membrane bound proteins and process for making them.
AU4545889A (en) Synthetic dna derived recombinant hiv antigens
DE3377989D1 (en) Coding dna fragments for polypeptides containing at least one antigenic determinant of the papillomavirus particularly of the la hpv type and corresponding polypeptides
AU4880093A (en) Retrovirus from the HIV group and its use
CA2101639A1 (en) Herpes simplex virus-1 deletion variants and vaccines thereof
EP0244234A3 (en) Transformation of trichoderma
EP0431541A3 (en) Toxoplasma gondii antigen, its production and use
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
ZA918462B (en) Expression system.
AU539195B2 (en) Determination of low density lipoproteins
HK107595A (en) Recombinant herpes simplex gb-gd vaccine
ES2117125T3 (en) PROCEDURE FOR THE PREPARATION OF TERTIARY BUTILAMINE.
ES8505253A1 (en) Production of herpes simplex viral proteins.
GB8414354D0 (en) Purifying protein
EP0184575A3 (en) Transformed yeasts producing lysozyme, plasmids used for this transformation, and uses thereof
AU4569293A (en) Anti-feline immunodeficiency virus (fiv) vaccines
AU4850697A (en) Recombinant adenovirus vaccines
AU3188993A (en) Soluble ldl receptor, its production and use
EP0299354A3 (en) Monoclonal antibodies against protein e7 of the human papilloma virus type 16, their production process and their use
AU1678783A (en) Production of herpes simplex viral proteins
GR3007491T3 (en)
TW342413B (en) Novel toxins isolated from Bracon Hebetor
AU3395993A (en) Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use
AU5773194A (en) Use of lymphocytes transformed with herpesvirus saimiri in a process for replicating viruses of the HIV type which cause immune deficiency